维普期刊资源整合服务平台（V6.5）

39篇 您的检索式：作者名="Endrenyi L"

选中清除导出查看参考文献查看引证文献引用追踪共2页首页上一页第1页下一页末页 /2 跳转

	题名	作者	年代	出处	被引量
1	Hypothesis : comparisons of inter- and intra-individual variations can substitute for twin studies in drug research 显示文摘	Kalow W Tang BK Endrenyi L	1998	Pharmacogenetics1998，8，4：	1
2	Sample sizes for designing bio- equivalence studies for high variable drugs 显示文摘	TOTHFALUSI L ENDRENYI L	2012	J Pharm Pharm Sci2012，15，1：	1
3	Regulatory and study condi- tions for the determination of bioequivalence of highly variable drugs显示文摘	ENDRENYI L TOTHFALUSI L	2009	J Pharm Pharm Sci2009，12，1：	1
4	On the interchangeability of biologic drug products显示文摘	Endrenyi L Chang C Chow S C	2013	Statistics in medicine2013，32，3：	1
5	Evaluation of bioequivalenee for highly-variable drugs with scaled average bioequivalenee 显示文摘	TOTHFALUSI L ENDRENYI L GARCIA-ARETA A	2009	Clin Pharmacokinet2009，48，11：	1
6	Regulatory conditions for the determination of bioequivalence of highly variable drugs 显示文摘	Endrenyi L Tothfalusi L	2009	J Pharm Pharmaceut Sci2009，12，1：	1
7	Integrated treatment of adequacy and security in bulk power system reliability evaluations 显示文摘	LEITE DA SILVA A M ENDRENYI J WANG L	1993	IEEE Transactions on Power Systems1993，8，1：	1
8	Individual bioequivalence: attractive in principle,difficult in practice显示文摘	Endrenyi L Amidon GL Midha KK	1998	Pharm Res1998，15，：	1
9	Scientific considera- tion for assessing biosimilar products 显示文摘	CHOW SC WANG J ENDRENYI L	2013	Stat Med2013，32，：	1
10	CYP2D6 and DRD2 genes differentially impact pharmacodynamic sensitivity and time course of prolactin response to perphenazine显示文摘	AKLILLU E KALOW W ENDRENYI L	2007	Phar- macogenet Genomics2007，17，11：	1
11	Probabilistic evalua- tion of the effect of maintenance on reliability - an application显示文摘	ENDRENYI J ANDERS G J da Silva A M L	1998	IEEE Transactions on Power Systems1998，13，2：	1
12	Sample sizes for designing bioequivalence studies for highly variable drugs 显示文摘	Tothfalusi L Endrenyi L	2012	J Pharm Pharm Sci2012，15，1：	1
13	Scientific factors for assessing biosimilarity and drug Interchangeability of follow-on biologics显示文摘	CHOW SC ENDRENYI L LACHENBRUCH PA	2011	Biosimilars2011，，1：	1
14	Individual bioequivalence-has it time come显示文摘	Endrenyi L Midha K K	1998	European Journal of Pharmaceutical Sciences1998，6，：	1
15	Probabilis- tic evaluation of the effect of maintenance on reliability-An application显示文摘	ENDRENYI J ANDERS G J DA SILVA A M L	1998	IEEE Transactions on Power Systems1998，13，2：	1
16	Determination of bioequivalence for drugs with narrow therapeutic index: reduction of the regulato- ry burden显示文摘	ENDRENYI L TOTHFALUSI L	2013	JPharmPharmSci2013，16，5：	1
17	Scientific considerations for assessing biosimilar products显示文摘	CHOW SC WANG J ENDRENYI L	2013	Stat Med2013，32，3：	1
18	Scaling or wider bioequivalence limits for highly variable drugs and for the special case of Cmax显示文摘	Tothfalusi L Endrenyi L Midha K	2003	Int J Clin Pharmacol Ther2003，41，：	1
19	Limits for the scaled average bioequivalence of highly variable drugs and drug products显示文摘	Tothfalusi L Endrenyi L	2003	Pharm Res2003，20，：	1
20	Individual bio- equivalence: attractive in principle, difficult in practice 显示文摘	ENDRENYI L AMIDON GL MIDHA KK	1998	Pharm Res1998，15，9：	1

返回顶部每页显示：

共2页首页上一页第1页下一页末页 /2 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示